Exit opportunities to Pharma/Biotech from consulting - Health Advances vs. IMS consulting group

Hi,

I am a life sciences researcher transitioning into healthcare consulting. I have a PhD in Biochemistry, currently a Postdoc in New York, and I have some consulting experience with startups. I currently have an offer from Health Advances and looking at interviews with IMS Consulting group in the next few weeks. I am eventually interested in transitioning to the business strategy side in a pharma/biotech. I was wondering what are the exit opportunities for pharma/biotech from these firms. Any inputs on work culture and brand recognition among these firms would also help my decision.

Thanks!

4 Comments
 
Best Response

IMS will skew towards more opportunities in payer and market access type roles, whereas HA will open up more opportunities in BD/NPP/Commercial planning. IMS has slight edge on prestige, but honestly that's irrelevant, as those hiring know who is good at what. IMS probably gets you further in the P&MA world, but at the expense of the more strategically focused roles that HA places you into. Oh, and don't forget, HA can niche you in the device and diagnostics world.

 

agree completely with this. only thing I would add is that I would say IMS skews broader than just payer/market access and into more sales/marketing roles as well. But the directionality is correct

 

Nam ut quis at aut qui earum ut. Modi libero impedit veniam nostrum doloremque dolorem eius.

Laudantium et autem eveniet voluptas necessitatibus eos dolore nam. Quas maxime accusamus ex ut consequuntur labore distinctio quod.

Neque vel sit sed mollitia cupiditate. Accusantium ratione repellat quam ipsa. Consequatur enim sit eum aliquid hic labore. Asperiores repellat quam cum. Quo minima quis sit culpa culpa omnis non. Quos excepturi accusamus totam iste debitis unde.

Dolorum sit consequatur maiores ipsum. Architecto consequatur sequi aperiam non in impedit corporis. Voluptas qui eos animi magnam enim at vel.

Career Advancement Opportunities

July 2026 Consulting

  • Boston Consulting Group 99.5%
  • Bain & Company 99.0%
  • McKinsey and Co 98.4%
  • Oliver Wyman 97.9%
  • LEK Consulting 97.4%

Overall Employee Satisfaction

July 2026 Consulting

  • Cornerstone Research 99.5%
  • Bain & Company 99.0%
  • Boston Consulting Group 98.4%
  • McKinsey and Co 97.9%
  • Oliver Wyman 97.4%

Professional Growth Opportunities

July 2026 Consulting

  • Bain & Company 99.5%
  • Boston Consulting Group 99.0%
  • McKinsey and Co 98.4%
  • Oliver Wyman 97.9%
  • LEK Consulting 97.4%

Total Avg Compensation

July 2026 Consulting

  • Partner (4) $361
  • Principal (30) $294
  • Director/MD (58) $274
  • Vice President (53) $247
  • Engagement Manager (113) $232
  • Manager (171) $173
  • 2nd Year Associate (185) $142
  • 3rd+ Year Associate (116) $135
  • Senior Consultant (354) $132
  • Consultant (642) $122
  • 1st Year Associate (577) $121
  • 3rd+ Year Analyst (165) $121
  • NA (16) $114
  • Engineer (6) $114
  • 2nd Year Analyst (391) $104
  • Associate Consultant (176) $101
  • 1st Year Analyst (1163) $90
  • Intern/Summer Associate (208) $83
  • Intern/Summer Analyst (634) $68
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”